Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2005
12/13/2005US6974806 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/08/2005WO2005117242A1 Method and installation means for installing an electrical machine
12/08/2005WO2005116015A1 Chromanol derivatives, method for the production thereof, and use thereof as an anti-inflammatory drug
12/08/2005WO2005116012A1 Pyrrolidine derivative
12/08/2005WO2005116009A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
12/08/2005WO2005115992A1 Theramutein modulators
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115987A1 Therapeutic compounds: pyridine n oxide scaffold
12/08/2005WO2005115986A1 Therapeutic compounds: pyridine as scaffold
12/08/2005WO2005115981A2 A process for the preparation of 1-(9h-carbazol-4-yloxy)-3-2-(-methoxyphenoxy)-ethyl amino-propan-2-ol
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115384A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
12/08/2005WO2005115145A2 Quinone substituted quinazoline and quinoline kinase inhibitors
12/08/2005WO2005077932A3 Chemokine receptor antagonists
12/08/2005WO2005075436A3 Novel inhibitors of glutaminyl cyclase
12/08/2005WO2005034940A3 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/08/2005WO2004096134A3 Substituted 1,4-diazepines and uses thereof
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272798 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
12/08/2005US20050272794 Pyrazole derivatives, compositions containing such compounds and methods of use
12/08/2005US20050272793 Pyrazole compounds and uses related thereto
12/08/2005US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272785 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272736 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2005US20050272727 As antitumor and anticancer agents
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272699 1- and 2-substituted with carbo- or heterocyclic groups, e.g., 3-[4-(5-Difluoromethoxy-3-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2-fluoro-phenyl)-acrylonitrile; inhibit the production of IL-2.
12/08/2005US20050272675 Methods for isolating crystalline form I of 5-azacytidine
12/08/2005US20050272036 Ketones
12/08/2005US20050271592 Optical diagnostic and therapeutic agents and compositions
12/08/2005DE3745196B4 1,2,4-Benzotriazine oxide derivs. - used for radio-sensitising hypoxic tumour cells and selectively killing hypoxic tumour cells
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2567813A1 Theramutein modulators
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2565065A1 Therapeutic compounds: pyridine as scaffold
12/08/2005CA2564668A1 Pyrrolidine derivatives
12/07/2005EP1602655A1 Benzofuran derivative
12/07/2005EP1601670A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
12/07/2005EP1601669A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/07/2005EP1601664A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
12/07/2005EP1601659A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
12/07/2005EP1601657A1 Pyrazole modulators of atp-binding cassette transporters
12/07/2005EP1601654A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
12/07/2005EP1601653A1 Process for the production of substituted nicotinic acid esters
12/07/2005EP1601357A1 Heterocyclic kinase inhibitors: methods of use and synthesis
12/07/2005EP1527053B1 Process for preparing rizatriptan
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1175410B1 Pesticidal triazine derivatives
12/07/2005EP1097138B1 Pharmaceutical compositions comprising 2-quinolones
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1705659A Large conductance calcium-activated k channel opener
12/07/2005CN1705658A Process for making spirolactone compounds
12/07/2005CN1705653A 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/07/2005CN1704406A Intermediate for the preparation of epimino
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230432C Substituted phenyl-Piperazine derivatives, their preparation and use
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/07/2005CN1230416C Pharmaceutical compounds
12/07/2005CN1230163C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972293 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba)
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/06/2005US6972288 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
12/06/2005CA2173257C Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
12/04/2005CA2568914A1 Therapeutic agents, and methods of making and using the same
12/01/2005WO2005114331A1 Resist compound and resist composition
12/01/2005WO2005113547A1 Ionic-liquid-supporting crown compound
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/01/2005WO2005113535A2 Pyrazinylmethyl lactam derivatives
12/01/2005WO2005113531A1 Light-emitting device material and light-emitting device
12/01/2005WO2005113527A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005WO2005113514A2 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113513A2 Aryl sulfonamides
12/01/2005WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113509A1 Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
12/01/2005WO2005113501A1 Neurogenic pain control agent composition
12/01/2005WO2005113494A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
12/01/2005WO2005112932A2 Raf modulators and methods of use
12/01/2005WO2005112925A1 Aryl sulfonamides
12/01/2005WO2005112923A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005WO2005112630A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
12/01/2005WO2005100285A3 Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds
12/01/2005WO2005095345A3 Heteroaryl guanidines as inhibitors of viral replication